Funder
Pediatric Brain Tumor Consortium Grant
National Center for Research Resources
American Lebanese Syrian Associated Charities
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Immunology,Immunology and Allergy
Reference23 articles.
1. Gururangan S, Reap E, Reynolds R, Grant G, Onar-Thomas A, Kocak M, Baxter P, Pollack I, Phillips P, Boyett JM, Fouladi M, Mitchell DA (2016) Immunologic profile of patients with newly-diagnosed medulloblastoma at initial diagnosis and during standard radiation and chemotherapy (PBTC-N11). Neuro Oncol 18(3):iii118
2. Dolecek TA, Propp JM, Stroup NE, Kruchko C (2012) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005–2009. Neuro Oncol 14(Suppl 5):v1–49. doi:
10.1093/neuonc/nos218
3. Gajjar A, Chintagumpala M, Ashley D, Kellie S, Kun LE, Merchant TE, Woo S, Wheeler G, Ahern V, Krasin MJ, Fouladi M, Broniscer A, Krance R, Hale GA, Stewart CF, Dauser R, Sanford RA, Fuller C, Lau C, Boyett JM, Wallace D, Gilbertson RJ (2006) Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial. Lancet Oncol 7(10):813–820. doi:
10.1016/S1470-2045(06)70867-1
4. Gururangan S, Krauser J, Watral MA, Driscoll T, Larrier N, Reardon DA, Rich JN, Quinn JA, Vredenburgh JJ, Desjardins A, McLendon RE, Fuchs H, Kurtzberg J, Friedman HS (2008) Efficacy of high-dose chemotherapy or standard salvage therapy in patients with recurrent medulloblastoma. Neuro Oncol 10(5):745–751. doi:
10.1215/15228517-2008-044
5. Jackson CM, Lim M, Drake CG (2014) Immunotherapy for brain cancer: recent progress and future promise. Clin Cancer Res 20(14):3651–3659. doi:
10.1158/1078-0432.CCR-13-2057
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献